Pubblicazioni

Modulating undruggable targets to overcome cancer therapy resistance

2022 - DRUG RESISTANCE UPDATES

Passirani, C.; Vessieres, A.; La Regina, G.; Link, W.; Silvestri, R.

Human estrogen receptor Î± antagonists, part 2: Synthesis driven by rational design, in vitro antiproliferative, and in vivo anticancer evaluation of innovative coumarin-related antiestrogens as breast cancer suppressants

2022 - EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY

Kurtanovic, N.; Tomasevic, N.; Matic, S.; Mitrovic, M. M.; Kostic, D. A.; Sabatino, M.; Antonini, L.; Ragno, R.; Mladenovic, M.

Advances in pharmacotherapy for advanced thyroid cancer of follicular origin (PTC, FTC). New approved drugs and future therapies

2022 - EXPERT OPINION ON PHARMACOTHERAPY

Elia, G.; Ferrari, S. M.; Ragusa, F.; Paparo, S. R.; Mazzi, V.; Ulisse, S.; Benvenga, S.; Antonelli, A.; Fallahi, P.

Long-term response to immuno-oncology after discontinuation for immuno-related pneumonia in metastatic renal carcinoma: a case report

2022 - ANTI-CANCER DRUGS

Stellato, M.; Foderaro, S.; Tonini, G.; Vincenzi, B.; Santini, D.

Therapeutic Potential of Marine Peptides in Prostate Cancer: Mechanistic Insights

2022 - MARINE DRUGS

Ahmed, Salman; Alam, Waqas; Jeandet, Philippe; Aschner, Michael; Alsharif, Khalaf F.; Saso, Luciano; Khan, Haroon

Pinus mugo Essential Oil Impairs STAT3 Activation through Oxidative Stress and Induces Apoptosis in Prostate Cancer Cells

2022 - MOLECULES

Ashiq Thalappil, Muhammed; Butturini, Elena; Carcereri de Prati, Alessandra; Bettin, Ilaria; Antonini, Lorenzo; Sapienza, FILIPPO UMBERTO; Garzoli, Stefania; Ragno, Rino; Mariotto, Sofia

Binding Motifs in the Naked Complexes of Target Amino Acids with an Excerpt of Antitumor Active Biomolecule: An Ion Vibrational Spectroscopy Assay

2021 - CHEMISTRY-A EUROPEAN JOURNAL

Chiavarino, B.; Sinha, R. K.; Crestoni, M. E.; Corinti, D.; Filippi, A.; Fraschetti, C.; Scuderi, D.; Maitre, P.; Fornarini, S.

The INCH trial - Induction chemotherapy in patients with bulky anal canal cancer: evaluation of the pilot phase

2021 - ANTICANCER RESEARCH

De Felice, F.; Fallarino, A.; Iafrate, F.; Maiuri, V.; Galloni, G.; Colonna, G. T.; De Pietro, R.; Chiarello, G.; Marchetti, C.; Bulzonetti, N.; Musio, D.; Tombolini, V.

Survival and toxicity of weekly cisplatin chemoradiotherapy versus three-weekly cisplatin chemoradiotherapy for head and neck cancer: a systematic review and meta-analysis endorsed by the Italian Association of Radiotherapy and Clinical Oncology (AIRO)

2021 - CRITICAL REVIEWS IN ONCOLOGY HEMATOLOGY

De Felice, F.; Belgioia, L.; Alterio, D.; Bonomo, P.; Maddalo, M.; Paiar, F.; Denaro, N.; Corvo, R.; Merlotti, A.; Bossi, P.; Pappagallo, G. L.; D' Angelillo, R. M.; Magrini, S. M.; Arcangeli, S.

The importance of tumor stem cells in glioblastoma resistance to therapy

2021 - INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES

Mattei, V.; Santilli, F.; Martellucci, S.; Monache, S. D.; Fabrizi, J.; Colapietro, A.; Angelucci, A.; Festuccia, C.

Exocrine pancreatic insufficiency and somatostatin analogs in patients with neuroendocrine neoplasia

2021 - EXPERT OPINION ON DRUG SAFETY

Panzuto, F.; Magi, L.; Rinzivillo, M.

Design and synthesis of new withaferin A inspired hedgehog pathway inhibitors

2021 - CHEMISTRY-A EUROPEAN JOURNAL

Bonandi, E.; Mori, M.; Infante, P.; Basili, I.; Di Marcotullio, L.; Calcaterra, A.; Catti, F.; Botta, B.; Passarella, D.

Pha-680626 is an effective inhibitor of the interaction between aurora-a and n-myc

2021 - INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES

Boi, D.; Souvalidou, F.; Capelli, D.; Polverino, F.; Marini, G.; Montanari, R.; Pochetti, G.; Tramonti, A.; Contestabile, R.; Trisciuoglio, D.; Carpinelli, P.; Ascanelli, C.; Lindon, C.; De Leo, A.; Saviano, M.; Di Santo, R.; Costi, R.; Guarguaglini, G.; Paiardini, A.

Proteasome inhibition by bortezomib parallels a reduction in head and neck cancer cells growth, and an increase in tumor-infiltrating immune cells

2021 - SCIENTIFIC REPORTS

Benvenuto, M.; Ciuffa, S.; Focaccetti, C.; Sbardella, D.; Fazi, S.; Scimeca, M.; Tundo, G. R.; Barillari, G.; Segni, M.; Bonanno, E.; Manzari, V.; Modesti, A.; Masuelli, L.; Coletta, M.; Bei, R.

Endothelin-1 drives invadopodia and interaction with mesothelial cells through ILK

2021 - CELL REPORTS

Masi, I.; Caprara, V.; Spadaro, F.; Chellini, L.; Sestito, R.; Zancla, A.; Rainer, A.; Bagnato, A.; Rosano, L.

ImmuneOncology-tyrosine kinase inhibitors combination, sometimes less is more

2021 - INTERNATIONAL IMMUNOPHARMACOLOGY

Stellato, M.; Santini, D.

Cardiac magnetic resonance imaging of transient myocardial dysfunction in a patient treated with checkpoint-targeted immunotherapy

2021 - EUROPEAN JOURNAL OF CANCER

Camastra, Giovanni; Arcari, Luca; Ciolina, Federica; Danti, Massimiliano; Cacciotti, Luca

ERAP1 Controls the Interaction of the Inhibitory Receptor KIR3DL1 With HLA-B51:01 by Affecting Natural Killer Cell Function

2021 - FRONTIERS IN IMMUNOLOGY

D'Amico, Silvia; D'Alicandro, Valerio; Compagnone, Mirco; Tempora, Patrizia; Guida, Giusy; Romania, Paolo; Lucarini, Valeria; Melaiu, Ombretta; Falco, Michela; Algeri, Mattia; Pende, Daniela; Cifaldi, Loredana; Fruci, Doriana

ERAP1 Controls the Interaction of the Inhibitory Receptor KIR3DL1 With HLA-B51:01 by Affecting Natural Killer Cell Function

2021 - FRONTIERS IN IMMUNOLOGY

Osimertinib beyond disease progression in T790M EGFR-positive NSCLC patients: a multicenter study of cliniciansâ attitudes

2020 - CLINICAL & TRANSLATIONAL ONCOLOGY.

Cortellini, A.; Leonetti, A.; Catino, A.; Pizzutillo, P.; Ricciuti, B.; De Giglio, A.; Chiari, R.; Bordi, P.; Santini, D.; Giusti, R.; De Tursi, M.; Brocco, D.; Zoratto, F.; Rastelli, F.; Citarella, F.; Russano, M.; Filetti, M.; Marchetti, P.; Berardi, R.; Torniai, M.; Cortinovis, D.; Sala, E.; Maggioni, C.; Follador, A.; Macerelli, M.; Nigro, O.; Tuzi, A.; Iacono, D.; Migliorino, M. R.; Banna, G.; Porzio, G.; Cannita, K.; Ferrara, M. G.; Bria, E.; Galetta, D.; Ficorella, C.; Tiseo, M.

Alvaxanthone, a thymidylate synthase inhibitor with nematocidal and tumoricidal activities

2020 - MOLECULES

Maj, P.; Mori, M.; Sobich, J.; Markowicz, J.; Uram, L.; Zielinski, Z.; Quaglio, D.; Calcaterra, A.; Cau, Y.; Botta, B.; Rode, W.

Short-termÂ outcome of cytoreductive surgery and hyperthermic intraperitoneal chemotherapy used as treatment of colo-rectal carcinomatosis: a multicentric study

2020 - UPDATES IN SURGERY

Macri, A.; Arcoraci, V.; Belgrano, V.; Caldana, M.; Carbonari, L.; Cioppa, T.; De Cian, F.; De Manzoni, G.; De Simone, M.; Giardina, C.; Muffatti, F.; Orsenigo, E.; Robella, M.; Roviello, F.; Saladino, E.; Sammartino, P.; Vaira, M.

Aptamer-based in vivo therapeutic targeting of glioblastoma

2020 - MOLECULES

Cesarini, V.; Scopa, C.; Silvestris, D. A.; Scafidi, A.; Petrera, V.; Del Baldo, G.; Gallo, A.

Blinatumomab for Acute Lymphoblastic Leukemia: The First Bispecific T-Cell Engager Antibody to Be Approved by the EMA for Minimal Residual Disease

2020 - THE ONCOLOGIST

Ali, S.; Moreau, A.; Melchiorri, D.; Camarero, J.; Josephson, F.; Olimpier, O.; Bergh, J.; Karres, D.; Tzogani, K.; Gisselbrecht, C.; Pignatti, F.

Neoadjuvant endocrine therapy in breast cancer. Current knowledge and future perspectives

2020 - INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES

Barchiesi, G.; Mazzotta, M.; Krasniqi, E.; Pizzuti, L.; Marinelli, D.; Capomolla, E.; Sergi, D.; Amodio, A.; Natoli, C.; Gamucci, T.; Vizza, E.; Marchetti, P.; Botti, C.; Sanguineti, G.; Ciliberto, G.; Barba, M.; Vici, P.